Document:

Exhibit 10.2

 

EXECUTION VERSION

 

NEITHER THIS SECURITY NOR
THE SECURITIES FOR WHICH THIS SECURITY IS EXERCISABLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES
COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES
ACT”), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES
ACT OR PURSUANT TO AN AVAILABLE EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS OF THE SECURITIES
ACT AND IN ACCORDANCE WITH APPLICABLE STATE SECURITIES LAWS. THIS SECURITY AND THE SECURITIES ISSUABLE UPON EXERCISE OF THIS SECURITY
MAY BE PLEDGED IN CONNECTION WITH A BONA FIDE MARGIN ACCOUNT OR OTHER LOAN SECURED BY SUCH SECURITIES.

 

COMMON STOCK PURCHASE WARRANT

 

 

DIGIPATH, CORP.

 

Warrant Shares: 3,000,000 Issue Date: April 19, 2014

 

THIS COMMON STOCK
PURCHASE WARRANT (the “Warrant”) certifies that, for value received, Steven D. Barbee (the “Holder”)
is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on
or after the Issue Date (as defined above) and on or prior to the close of business on the fifth (5th) anniversary of
the Issue Date (the “Termination Date”) but not thereafter, to subscribe for and purchase from DigiPath, Corp.,
a Nevada corporation (the “Company”), up to 3,000,000 shares (the “Warrant Shares”) of Common
Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section
2(b).

Section 1.Definitions.
Capitalized terms used and not otherwise defined herein shall have the meanings set forth in that certain Consulting Agreement
(the “Purchase Agreement”), dated April 18, 2014, among the Company and the Holder.

Section 2.Exercise.

a)               
Exercise of Warrant. Exercise of the purchase rights represented by this Warrant may
be made, in whole or in part, at any time and from time to time on or after the Issue Date and on or before the Termination Date
by delivery to the Company of a duly executed facsimile copy of the Notice of Exercise Form annexed hereto (or such other office
or agency of the Company as it may designate by notice in writing to the registered Holder at the address of the Holder appearing
on the books of the Company); and, within 3 Trading Days of the date said Notice of Exercise is delivered to the Company, the Company
shall have received payment of the aggregate Exercise Price of the shares thereby purchased by internal Company transfers (as result
of Change of Control Earned Bonus per Constant Agreement between Company and Holder Executed on April 18, 2014), or wire transfer
or cashier’s check drawn on a United States bank, unless payment is being made by cashless exercise as provided in Section
2(c) below. This Warrant shall be deemed to have been exercised, (i) in the case of a cashless exercise under Section 2(b), on
the date the Notice of Exercise is delivered to the Company, or (ii) otherwise on the date the Exercise Price is received by the
Company (the "Exercise Date"). Notwithstanding anything herein to the contrary, the Holder shall not be required to physically
surrender this Warrant to the Company until the Holder has purchased all of the Warrant Shares available hereunder and the Warrant
has been exercised in full, in which case the Holder shall surrender this Warrant to the Company for cancellation within 3 Trading
Days of the date the final Notice of Exercise is delivered to the Company. Partial exercises of this Warrant resulting in purchases
of a portion of the total number of Warrant Shares available hereunder shall have the effect of lowering the outstanding number
of Warrant Shares purchasable hereunder in an amount equal to the applicable number of Warrant Shares purchased. The Holder and
the Company shall maintain records showing the number of Warrant Shares purchased and the date of such purchases. In the event
of any dispute or discrepancy, the records of the Company shall be controlling and determinative in the absence of manifest error.
The Holder and any assignee, by acceptance of this Warrant, acknowledge and agree that, by reason of the provisions of this paragraph,
following the purchase of a portion of the Warrant Shares hereunder, the number of Warrant Shares available for purchase hereunder
at any given time may be less than the amount stated on the face hereof.

b)              
Exercise Price. The exercise price per share of the Common Stock under this Warrant
shall be $0.10, subject to adjustment hereunder (the “Exercise Price”).

c)               
Cashless Exercise. This Warrant may also be exercised by means of a “cashless
exercise” in which the Holder shall be entitled to receive a certificate for the number of Warrant Shares equal to the quotient
obtained by dividing [(A-B) (X)] by (A), where:

(A) = the VWAP
on the Trading Day immediately preceding the date of such election; “VWAP”
means, for any date, the price determined by the first of the following clauses that applies: (a) if the Common Stock is then listed
or quoted on a Trading Market, the daily volume weighted average price of the Common Stock for such date (or the nearest preceding
date) on the Trading Market on which the Common Stock is then listed or quoted for trading as reported by Bloomberg L.P. (based
on a Trading Day from 9:30 a.m. (New York City time) to 4:02 p.m. (New York City time)); (b)  if the OTC Bulletin Board is
not a Trading Market, the volume weighted average price of the Common Stock for such date (or the nearest preceding date) on the
OTC Bulletin Board; (c) if the Common Stock is not then quoted for trading on the OTC Bulletin Board and if prices for the Common
Stock are then reported in the “Pink Sheets” published by Pink Sheets, LLC (or a similar organization or agency succeeding
to its functions of reporting prices), the most recent bid price per share of the Common Stock so reported; or (d) in all
other cases, the fair market value of a share of Common Stock as determined by an independent appraiser selected in good faith
by the Holder and reasonably acceptable to the Company.

 

(B) = the Exercise
Price of this Warrant, as adjusted; and

 

(X) = the
number of Warrant Shares issuable upon exercise of this Warrant in accordance with the terms of this Warrant by means of a cash
exercise rather than a cashless exercise.

 

d)              
Automatic Cashless Exercises. 

                                                   
i.     Notwithstanding
anything herein to the contrary, on the Termination Date, this Warrant shall be automatically exercised via cashless exercise pursuant
to Section 2(c). 

                                                 
ii.     If
after one (1) year following the initial Closing Date, (i) the Company’s Common Stock has been listed or quoted for trading
on any Trading Market other than the OTC Bulletin Board for a period of ninety (90) consecutive Trading Days immediately preceding
the Forced Conversion Date, (ii) no default notice has been received by the Company from any such Trading Market during or with
respect to the foregoing time period, and (iii) the VWAP for any 20 out of 30 consecutive Trading Days immediately preceding the
Forced Conversion Date exceeds three times the Exercise Price (subject to appropriate and equitable adjustment for reverse and
forward stock splits, stock dividends, stock combinations and other similar transactions of the Common Stock that occur after the
Closing Date), then this Warrant shall be automatically exercised via cashless exercise pursuant to Section 2(c) immediately prior
to the closing of a Conversion Fundamental Transaction (provided, for the avoidance of doubt, such closing occurs after one (1)
year following the initial Closing Date). The date of such closing shall be deemed to be the “Exercise Date” for purposes
of this Section 2. The Holder may elect, by giving written notice of such election to the Company at least five (5) Trading Days
before the closing of a Conversion Fundamental Transaction, to avoid such an automatic cashless exercise by selling this Warrant
to the Company or its designated assignee, concurrently with such closing. The purchase price for such purchase shall be a cash
payment equal to the number of Warrant Shares for which this Warrant is exercisable immediately prior to such closing, multiplied
by the greater of (A) 200% of the original Exercise Price for each Warrant Share under Section 2(b) above (appropriately adjusted
for any stock splits, stock dividends and similar events), or (B) the aggregate Exercise Price for the number of Warrant Shares
(appropriately adjusted for any reverse and forward stock splits, stock dividends, stock combinations and other similar transactions
of the Common Stock that occur after the Closing Date) for which this Warrant is exercisable immediately prior to such closing,
divided by the Exercise Price immediately prior to such closing, multiplied by the VWAP on the last Trading Day prior to such closing.
Notice of any proposed Conversion Fundamental Transaction and such election shall be given to the Holder at least fifteen (15)
calendar days before such closing. In connection with such purchase, the Holder shall assign this Warrant to the Company or its
assignee, free and clear of any liens, claims or encumbrances other than transfer restrictions under applicable securities laws.

e)               
Holder’s Restrictions.  

                                                                            
i.         
Unless otherwise approved in writing by the Company, any individual exercise under Section
2(a) must be for at least 10,000 Warrant Shares (such number to be appropriately adjusted for any stock splits, stock dividends
and similar events). 

f)               
Mechanics of Exercise. 

                                                                            
i.         
Delivery of Certificates Upon Exercise. Certificates for shares purchased hereunder
shall be transmitted by the transfer agent of the Company to the Holder by crediting the account of the Holder’s prime broker
with the Depository Trust Company through its Deposit Withdrawal Agent Commission (“DWAC”) system if the Company
is a participant in such system and either (x) there is an effective Registration Statement permitting the resale of the Warrant
Shares by the Holder, or (y) such shares may be sold pursuant to Rule 144, and otherwise by physical delivery to the address specified
by the Holder in the Notice of Exercise, within 3 Trading Days from the delivery to the Company of the Notice of Exercise Form,
surrender of this Warrant (if required) and payment of the aggregate Exercise Price as set forth above (“Warrant Share
Delivery Date”). This Warrant shall be deemed to have been exercised on the Exercise Date. The Warrant Shares shall be
deemed to have been issued, and Holder or any other person so designated to be named therein shall be deemed to have become a holder
of record of such shares for all purposes, as of the date the Warrant has been exercised by payment to the Company of the Exercise
Price (or by cashless exercise) and all taxes required to be paid by the Holder, if any, pursuant to Section 2(e)(vi) prior to
the issuance of such shares, have been paid. If the Company fails for any reason to deliver to the Holder the Warrant Shares or
certificates evidencing the Warrant Shares subject to a Notice of Exercise by the seventh Trading Day after the Warrant Share Delivery
Date, the Company shall pay to the Holder, in cash, as liquidated damages and not as a penalty, for each $1,000 of Warrant Shares
subject to such exercise (based on the VWAP of the Common Stock on the date of the applicable Notice of Exercise), $7.00 per Trading
Day (increasing to $12.50 per Trading Day on the fifth Trading Day after such liquidated damages begin to accrue) for each Trading
Day after such Warrant Share Delivery Date until such shares or certificates are delivered. The exercise of any such rights shall
not prohibit the Holder from seeking to enforce damages pursuant to any other Section hereof or under applicable law. Notwithstanding
any portion of the foregoing to the contrary, if the Company fails to deliver to the Holder such certificate(s) or shares by the
Warrant Share Delivery Date pursuant to this Section 2(f)(i) because (i) the exercise by the Holder is in connection with a proposed
sale by the Holder of the Warrant Shares under Rule 144 promulgated under the Securities Act, and (ii) in connection with such
sale, the Holder has failed to deliver customary representation letters, as prepared by the brokerage firm of Holder in the ordinary
course of its business, appropriate to evidence compliance with such rule, then the liquidated damages provisions herein shall
not begin to accrue until the Trading Day immediately following the date that the Holder has delivered such representation letters.

                                                                          
ii.         
Delivery of New Warrants Upon Exercise. If this Warrant shall have been exercised in
part, the Company shall, at the request of a Holder and upon surrender of this Warrant certificate, at the time of delivery of
the certificate or certificates representing Warrant Shares, deliver to Holder a new Warrant evidencing the rights of Holder to
purchase the unpurchased Warrant Shares called for by this Warrant, which new Warrant shall in all other respects be identical
with this Warrant.

                                                                         
iii.         
Rescission Rights. If the Company fails to cause its transfer agent to transmit to
the Holder a certificate or certificates representing the Warrant Shares (or otherwise transmit such shares via DWAC to the Holder’s
DTC account) pursuant to this Section 2(e) by the Warrant Share Delivery Date, then until the Holder's receipt of such certificate
or certificates, the Holder will have the right to rescind such exercise.

                                                                         
iv.         
Compensation for Buy-In on Failure to Timely Deliver Certificates Upon Exercise. In
addition to any other rights available to the Holder, if the Company fails to cause its transfer agent to transmit to the Holder
a certificate or certificates representing the Warrant Shares (or otherwise transmit such shares via DWAC to the Holders DTC account)
pursuant to an exercise on or before the Warrant Share Delivery Date, and if after such date the Holder is required by its broker
to purchase (in an open market transaction or otherwise) or the Holder’s brokerage firm otherwise purchases, shares of Common
Stock to deliver in satisfaction of a sale by the Holder of the Warrant Shares which the Holder anticipated receiving upon such
exercise (a “Buy-In”), then the Company shall (1) pay in cash to the Holder the amount by which (x) the Holder’s
total purchase price (including brokerage commissions, if any) for the shares of Common Stock so purchased exceeds (y) the amount
obtained by multiplying (A) the number of Warrant Shares that the Company was required to deliver to the Holder in connection with
the exercise at issue times (B) the price at which the sell order giving rise to such purchase obligation was executed, and (2)
at the option of the Holder, either reinstate the portion of the Warrant and equivalent number of Warrant Shares for which such
exercise was not honored or deliver to the Holder the number of shares of Common Stock that would have been issued had the Company
timely complied with its exercise and delivery obligations hereunder. For example, if the Holder purchases Common Stock having
a total purchase price of $11,000 to cover a Buy-In with respect to an attempted exercise of shares of Common Stock with an aggregate
sale price giving rise to such purchase obligation of $10,000, under clause (1) of the immediately preceding sentence the Company
shall be required to pay the Holder $1,000. The Holder shall provide the Company written notice indicating the amounts payable
to the Holder in respect of the Buy-In and, upon request of the Company, evidence of the amount of such loss. Nothing herein shall
limit a Holder’s right to pursue any other remedies available to it hereunder, at law or in equity including, without limitation,
a decree of specific performance and/or injunctive relief with respect to the Company’s failure to timely deliver the Warrant
Shares or certificates representing shares of Common Stock upon exercise of the Warrant as required pursuant to the terms hereof.

                                                                           
v.         
No Fractional Shares or Scrip. No fractional shares or scrip representing fractional
shares shall be issued upon the exercise of this Warrant. As to any fraction of a share which Holder would otherwise be entitled
to purchase upon such exercise, the Company shall at its election, either pay a cash adjustment in respect of such final fraction
in an amount equal to such fraction multiplied by the Exercise Price or round up to the next whole share.

                                                                         
vi.         
Charges, Taxes and Expenses. Issuance of certificates for Warrant Shares shall be made
without charge to the Holder for any issue or transfer tax or other incidental expense in respect of the issuance of such certificate,
all of which taxes and expenses shall be paid by the Company, and such certificates shall be issued in the name of the Holder or
in such name or names as may be directed by the Holder; provided, however, that in the event certificates for Warrant
Shares are to be issued in a name other than the name of the Holder, this Warrant when surrendered for exercise shall be accompanied
by the Assignment Form attached hereto duly executed by the Holder; and the Company may require, as a condition thereto, the payment
of a sum sufficient to reimburse it for any transfer tax incidental thereto.

                                                                       
vii.         
Closing of Books. The Company will not close its stockholder books or records in any
manner which prevents the timely exercise of this Warrant, pursuant to the terms hereof.

Section 3.Certain
Adjustments.

a)               
Stock Dividends and Splits. If the Company, at any time while this Warrant is outstanding:
(A) pays a stock dividend or otherwise make a distribution or distributions on shares of its Common Stock or any other equity or
equity equivalent securities payable in shares of Common Stock (which, for avoidance of doubt, shall not include any shares of
Common Stock issued by the Company upon exercise of this Warrant), (B) subdivides outstanding shares of Common Stock into a larger
number of shares, (C) combines (including by way of reverse stock split) outstanding shares of Common Stock into a smaller number
of shares, or (D) issues by reclassification of shares of the Common Stock any shares of capital stock of the Company, then in
each case the Exercise Price shall be multiplied by a fraction of which the numerator shall be the number of shares of Common Stock
(excluding treasury shares, if any) outstanding immediately before such event and of which the denominator shall be the number
of shares of Common Stock outstanding immediately after such event and the number of shares issuable upon exercise of this Warrant
shall be proportionately adjusted such that the aggregate Exercise Price of this Warrant shall remain unchanged. Any adjustment
made pursuant to this Section 3(a) shall become effective immediately after the record date for the determination of stockholders
entitled to receive such dividend or distribution and shall become effective immediately after the effective date in the case of
a subdivision, combination or re-classification.

b)              
Subsequent Rights Offerings. The Company shall not, at any time while the Warrant is
outstanding, issue rights, options or warrants to all holders of Common Stock (and not to Holders) entitling them to subscribe
for or purchase shares of Common Stock at a price per share less than the VWAP at the record date mentioned below.

c)               
Pro Rata Distributions. The Company shall not, at any time while this Warrant is outstanding,
distribute to all holders of Common Stock (and not to Holders of the Warrants) evidences of its indebtedness or assets (including
cash and cash dividends) or rights or warrants to subscribe for or purchase any security other than the Common Stock.

d)              
Fundamental Transaction. If, at any time while this Warrant is outstanding, (A) the
Company effects any merger or consolidation of the Company with or into another Person, (B) the Company effects any sale of all
or substantially all of its assets in one or a series of related transactions, (C) any tender offer or exchange offer (whether
by the Company or another Person) is completed pursuant to which holders of Common Stock are permitted to tender or exchange their
shares for other securities, cash or property, or (D) the Company effects any reclassification of the Common Stock or any compulsory
share exchange pursuant to which the Common Stock is effectively converted into or exchanged for other securities, cash or property
(each “Fundamental Transaction”), then, upon any subsequent exercise of this Warrant, the Holder shall have
the right to receive, for each Warrant Share that would have been issuable upon such exercise immediately prior to the occurrence
of such Fundamental Transaction, the number of shares of Common Stock of the successor or acquiring corporation or of the Company,
if it is the surviving corporation, and any additional consideration (the “Alternate Consideration”) receivable
as a result of such merger, consolidation or disposition of assets by a holder of the number of shares of Common Stock for which
this Warrant is exercisable immediately prior to such event. For purposes of any such exercise, the determination of the Exercise
Price shall be appropriately adjusted to apply to such Alternate Consideration based on the amount of Alternate Consideration issuable
in respect of one share of Common Stock in such Fundamental Transaction, and the Company shall apportion the Exercise Price among
the Alternate Consideration in a reasonable manner reflecting the relative value of any different components of the Alternate Consideration.
If holders of Common Stock are given any choice as to the securities, cash or property to be received in a Fundamental Transaction,
then the Holder shall be given the same choice as to the Alternate Consideration it receives upon any exercise of this Warrant
following such Fundamental Transaction. To the extent necessary to effectuate the foregoing provisions, any successor to the Company
or surviving entity in such Fundamental Transaction shall issue to the Holder a new warrant consistent with the foregoing provisions
and evidencing the Holder’s right to exercise such warrant into Alternate Consideration. The terms of any agreement pursuant
to which a Fundamental Transaction is effected shall include terms requiring any such successor or surviving entity to comply with
the provisions of this Section 3(d) and insuring that this Warrant (or any such replacement security) will be similarly adjusted
upon any subsequent transaction analogous to a Fundamental Transaction. Notwithstanding anything to the contrary, in the event
of a Fundamental Transaction that is (1) an all cash transaction, (2) a “Rule 13e-3 transaction” as defined in Rule
13e-3 under the Securities Exchange Act of 1934, as amended, or (3) a Fundamental Transaction involving a person or entity not
traded on a national securities exchange, the Nasdaq Global Select Market, the Nasdaq Global Market, the Nasdaq Capital Market
or the OTC Bulletin Board, the Company or any successor entity shall pay at the Holder’s option, exercisable at any time
concurrently with or within 30 days after the consummation of the Fundamental Transaction, an amount of cash equal to the value
of this Warrant as determined in accordance with the Black Scholes Option Pricing Model obtained from the “OV” function
on Bloomberg L.P. using (i) a price per share of Common Stock equal to the VWAP of the Common Stock for the Trading Day immediately
preceding the date of consummation of the applicable Fundamental Transaction, (ii) a risk-free interest rate corresponding to the
U.S. Treasury rate for a period equal to the remaining term of this Warrant as of the date of consummation of the applicable Fundamental
Transaction and (iii) an expected volatility equal to the 100 day volatility obtained from the “HVT” function on Bloomberg
L.P. determined as of the Trading Day immediately following the public announcement of the applicable Fundamental Transaction..

e)               
Calculations. All calculations under this Section 3 shall be made to the nearest cent
or the nearest 1/100th of a share, as the case may be. For purposes of this Section 3, the number of shares of Common Stock deemed
to be issued and outstanding as of a given date shall be the sum of the number of shares of Common Stock (excluding treasury shares,
if any) issued and outstanding.

f)               
Voluntary Adjustment By Company. The Company may at any time during the term of this
Warrant reduce the then current Exercise Price to any lesser amount and for any period of time deemed appropriate by the Board
of Directors of the Company.

g)              
Notice to Holder. 

                                                                            
i.         
Adjustment to Exercise Price. Whenever the Exercise Price is adjusted pursuant to any
provision of this Section 3, the Company shall promptly mail to the Holder a notice setting forth the Exercise Price after such
adjustment and setting forth a brief statement of the facts requiring such adjustment. If the Company enters into a variable rate
transaction, despite the prohibition thereon in the Purchase Agreement, the Company shall be deemed to have issued Common Stock
or Common Stock Equivalents at the lowest possible conversion or exercise price at which such securities may be converted or exercised.

                                                                          
ii.         
Notice to Allow Exercise by Holder. If (A) the Company shall declare a dividend (or
any other distribution in whatever form) on the Common Stock; (B) the Company shall declare a special nonrecurring cash dividend
on or a redemption of the Common Stock; (C) the Company shall authorize the granting to all holders of the Common Stock rights
or warrants to subscribe for or purchase any shares of capital stock of any class or of any rights; (D) the approval of any stockholders
of the Company shall be required in connection with any reclassification of the Common Stock, any consolidation or merger to which
the Company is a party, any sale or transfer of all or substantially all of the assets of the Company, of any compulsory share
exchange whereby the Common Stock is converted into other securities, cash or property; (E) the Company shall authorize the voluntary
or involuntary dissolution, liquidation or winding up of the affairs of the Company; then, in each case, the Company shall cause
to be mailed to the Holder at its last address as it shall appear upon the Warrant Register of the Company, at least 20 calendar
days prior to the applicable record or effective date hereinafter specified, a notice stating (x) the date on which a record is
to be taken for the purpose of such dividend, distribution, redemption, rights or warrants, or if a record is not to be taken,
the date as of which the holders of the Common Stock of record to be entitled to such dividend, distributions, redemption, rights
or warrants are to be determined or (y) the date on which such reclassification, consolidation, merger, sale, transfer or share
exchange is expected to become effective or close, and the date as of which it is expected that holders of the Common Stock of
record shall be entitled to exchange their shares of the Common Stock for securities, cash or other property deliverable upon such
reclassification, consolidation, merger, sale, transfer or share exchange; provided that the failure to mail such notice or any
defect therein or in the mailing thereof shall not affect the validity of the corporate action required to be specified in such
notice. The Holder is entitled to exercise this Warrant during the period commencing on the date of such notice to the effective
date of the event triggering such notice.

Section 4.Transfer
of Warrant.

a)               
Transferability. Subject to compliance with any applicable securities laws and the
conditions set forth in Section 4(d) hereof, this Warrant and all rights hereunder (including, without limitation, any registration
rights) are transferable, in whole or in part, upon surrender of this Warrant at the principal office of the Company or its designated
agent, together with a written assignment of this Warrant substantially in the form attached hereto duly executed by the Holder
or its agent or attorney and funds sufficient to pay any transfer taxes payable upon the making of such transfer. Upon such surrender
and, if required, such payment, the Company shall execute and deliver a new Warrant or Warrants in the name of the assignee or
assignees and in the denomination or denominations specified in such instrument of assignment, and shall issue to the assignor
a new Warrant evidencing the portion of this Warrant not so assigned, and this Warrant shall promptly be cancelled. A Warrant,
if properly assigned, may be exercised by a new holder for the purchase of Warrant Shares without having a new Warrant issued.

b)              
New Warrants. This Warrant may be divided or combined with other Warrants upon presentation
hereof at the aforesaid office of the Company, together with a written notice specifying the names and denominations in which new
Warrants are to be issued, signed by the Holder or its agent or attorney. Subject to compliance with Section 4(a), as to any transfer
which may be involved in such division or combination, the Company shall execute and deliver a new Warrant or Warrants in exchange
for the Warrant or Warrants to be divided or combined in accordance with such notice. All Warrants issued on transfers or exchanges
shall be dated the original Issue Date and shall be identical with this Warrant except as to the number of Warrant Shares issuable
pursuant thereto. 

c)               
Warrant Register. The Company shall register this Warrant, upon records to be maintained
by the Company for that purpose (the “Warrant Register”), in the name of the record Holder hereof from time
to time. The Company may deem and treat the registered Holder of this Warrant as the absolute owner hereof for the purpose of any
exercise hereof or any distribution to the Holder, and for all other purposes, absent actual notice to the contrary.

d)              
Transfer Restrictions. The Warrant may only be disposed of in compliance with state
and federal securities laws.

Section 5.Miscellaneous.

a)               
No Rights as Stockholder Until Exercise. This Warrant does not entitle the Holder to
any voting rights or other rights as a stockholder of the Company prior to the exercise hereof as set forth in Section 2(e)(i).

b)              
Loss, Theft, Destruction or Mutilation of Warrant. The Company covenants that upon
receipt by the Company of evidence reasonably satisfactory to it of the loss, theft, destruction or mutilation of this Warrant
or any stock certificate relating to the Warrant Shares, and in case of loss, theft or destruction, of indemnity or security reasonably
satisfactory to it (which, in the case of the Warrant, shall not include the posting of any bond), and upon surrender and cancellation
of such Warrant or stock certificate, if mutilated, the Company will make and deliver a new Warrant or stock certificate of like
tenor and dated as of such cancellation, in lieu of such Warrant or stock certificate.

c)               
Saturdays, Sundays, Holidays, etc. If the last or appointed day for the taking of any
action or the expiration of any right required or granted herein shall not be a Business Day, then such action may be taken or
such right may be exercised on the next succeeding Business Day.

d)              
Authorized Shares. 

The Company covenants
that during the period the Warrant is outstanding, it will reserve from its authorized and unissued Common Stock a sufficient number
of shares to provide for the issuance of the Warrant Shares upon the exercise of any purchase rights under this Warrant. The Company
further covenants that its issuance of this Warrant shall constitute full authority to its officers who are charged with the duty
of executing stock certificates to execute and issue the necessary certificates for the Warrant Shares upon the exercise of the
purchase rights under this Warrant. The Company will take all such reasonable action as may be necessary to assure that such Warrant
Shares may be issued as provided herein without violation of any applicable law or regulation, or of any requirements of the Trading
Market upon which the Common Stock may be listed. The Company covenants that all Warrant Shares which may be issued upon the exercise
of the purchase rights represented by this Warrant will, upon exercise of the purchase rights represented by this Warrant, be duly
authorized, validly issued, fully paid and nonassessable and free from all taxes, liens and charges created by the Company in respect
of the issue thereof (other than taxes in respect of any transfer occurring contemporaneously with such issue).

Except and to
the extent as waived or consented to by the Holder, the Company shall not by any action, including, without limitation, amending
its certificate of incorporation or through any reorganization, transfer of assets, consolidation, merger, dissolution, issue or
sale of securities or any other voluntary action, avoid or seek to avoid the observance or performance of any of the terms of this
Warrant, but will at all times in good faith assist in the carrying out of all such terms and in the taking of all such actions
as may be necessary or appropriate to protect the rights of Holder as set forth in this Warrant against impairment. Without limiting
the generality of the foregoing, the Company will (a) not increase the par value of any Warrant Shares above the amount payable
therefor upon such exercise immediately prior to such increase in par value, (b) take all such action as may be necessary or appropriate
in order that the Company may validly and legally issue fully paid and nonassessable Warrant Shares upon the exercise of this Warrant,
and (c) use commercially reasonable efforts to obtain all such authorizations, exemptions or consents from any public regulatory
body having jurisdiction thereof as may be necessary to enable the Company to perform its obligations under this Warrant.

Before taking
any action which would result in an adjustment in the number of Warrant Shares for which this Warrant is exercisable or in the
Exercise Price, the Company shall obtain all such authorizations or exemptions thereof, or consents thereto, as may be necessary
from any public regulatory body or bodies having jurisdiction thereof.

e)               
Jurisdiction. All questions concerning the construction, validity, enforcement and
interpretation of this Warrant shall be governed by and construed and enforced in accordance with the internal laws of the State
of Kansas, without regard to the principles of conflict of laws thereof. Each party agrees that all legal proceedings concerning
the interpretation, enforcement and defense of the transactions (whether brought against a party hereto or its respective Affiliates,
directors, officers, shareholders, employees or agents) shall be commenced in the state and federal courts sitting in the County
of Sedgwick (the “Sedgwick Courts”). Each party hereto hereby irrevocably submits to the exclusive jurisdiction
of the Sedgwick Courts for the adjudication of any dispute hereunder or in connection herewith or with any transaction contemplated
hereby or discussed, and hereby irrevocably waives, and agrees not to assert in any suit, action or proceeding, any claim that
it is not personally subject to the jurisdiction of such Sedgwick Courts, or such Los Angeles Courts are improper or inconvenient
venue for such proceeding. Each party hereby irrevocably waives personal service of process and consents to process being served
in any such suit, action or proceeding by mailing a copy thereof via registered or certified mail or overnight delivery (with evidence
of delivery) to such party at the address in effect for notices to it under this Warrant and agrees that such service shall constitute
good and sufficient service of process and notice thereof. Nothing contained herein shall be deemed to limit in any way any right
to serve process in any other manner permitted by applicable law. Each party hereto hereby irrevocably waives, to the fullest extent
permitted by applicable law, any and all right to trial by jury in any legal proceeding arising out of or relating to this Warrant
or the transactions contemplated hereby. If either party shall commence an action or proceeding to enforce any provisions of this
Warrant, then the prevailing party in such action or proceeding shall be reimbursed by the other party for its attorney’s
fees and other costs and expenses reasonably incurred in the investigation, preparation and prosecution of such action or proceeding.

f)               
Restrictions. The Holder acknowledges that the Warrant Shares acquired upon the exercise
of this Warrant, if not registered, will have restrictions upon resale imposed by state and federal securities laws.

g)              
Nonwaiver and Expenses. No course of dealing or any delay or failure to exercise any
right hereunder on the part of Holder shall operate as a waiver of such right or otherwise prejudice Holder’s rights, powers
or remedies, notwithstanding the fact that all rights hereunder terminate on the Termination Date. If the Company willfully and
knowingly fails to comply with any provision of this Warrant, which results in any material damages to the Holder, the Company
shall pay to Holder such amounts as shall be sufficient to cover any costs and expenses including, but not limited to, reasonable
attorneys’ fees, including those of appellate proceedings, incurred by Holder in collecting any amounts due pursuant hereto
or in otherwise enforcing any of its rights, powers or remedies hereunder.

h)              
Notices. Any notice, request or other document required or permitted to be given or
delivered to the Holder by the Company shall be delivered in accordance with the notice provisions of the Purchase Agreement.

i)                
Limitation of Liability. No provision hereof, in the absence of any affirmative action
by Holder to exercise this Warrant to purchase Warrant Shares, and no enumeration herein of the rights or privileges of Holder,
shall give rise to any liability of Holder for the purchase price of any Common Stock or as a stockholder of the Company, whether
such liability is asserted by the Company or by creditors of the Company.

j)                
Remedies. Holder, in addition to being entitled to exercise all rights granted by law,
including recovery of damages, will be entitled to specific performance of its rights under this Warrant. The Company agrees that
monetary damages would not be adequate compensation for any loss incurred by reason of a breach by it of the provisions of this
Warrant and hereby agrees to waive and not to assert the defense in any action for specific performance that a remedy at law would
be adequate.

k)              
Successors and Assigns. Subject to applicable securities laws, this Warrant and the
rights and obligations evidenced hereby shall inure to the benefit of and be binding upon the successors of the Company and the
successors and permitted assigns of Holder. The provisions of this Warrant are intended to be for the benefit of all Holders from
time to time of this Warrant and shall be enforceable by the Holder or holder of Warrant Shares.

l)                
Amendment. This Warrant may be modified or amended or the provisions hereof waived
with the written consent of the Company and the Holder.

m)            
Severability. Wherever possible, each provision of this Warrant shall be interpreted
in such manner as to be effective and valid under applicable law, but if any provision of this Warrant shall be prohibited by or
invalid under applicable law, such provision shall be ineffective to the extent of such prohibition or invalidity, without invalidating
the remainder of such provisions or the remaining provisions of this Warrant.

n)              
Headings. The headings used in this Warrant are for the convenience of reference only
and shall not, for any purpose, be deemed a part of this Warrant.

 

********************

 

IN WITNESS WHEREOF,
the Company has caused this Warrant to be executed by its officer thereunto duly authorized as of the date first above indicated.

 

	
        DIGIPATH, CORP.

         

         

	
        By:_____/s/ Steven D.
        Barbee_____________________________________

        Name: Steven Denny Barbee

        Title: President & Director

         

 

 

 

 

 

 

 

 

 

 

 

 

 

    	 

    	 

    

 

NOTICE OF EXERCISE

 

To:DIGIPATH,
CORP.

		RE:	Warrant originally issued on or about April 18, 2014 to ____________________ for ____________ Warrant
Shares.

 

(1) 
The undersigned hereby elects to purchase *(not less than 10,000) _______________ Warrant
Shares of the Company pursuant to the terms of the attached Warrant (only if exercised in full), and tenders herewith payment of
the exercise price in full, together with all applicable transfer taxes, if any.

(2) 
Payment shall take the form of (check applicable box):

[ ] in lawful
money of the United States; or

[ ] the cancellation
of such number of Warrant Shares as is necessary, in accordance with the formula set forth in subsection 2(c), to exercise this
Warrant with respect to the maximum number of Warrant Shares purchasable pursuant to the cashless exercise procedure set forth
in subsection 2(c).

(3) 
Please issue a certificate or certificates representing said Warrant Shares in the name of
the undersigned or in such other name as is specified below:

_______________________________

 

 

The Warrant Shares shall be delivered to the
following DWAC Account Number or by physical delivery of a certificate to:

 

_______________________________

 

_______________________________

 

_______________________________

 

(4) Accredited Investor.
The undersigned is an “accredited investor” as defined in Regulation D promulgated under the Securities Act of 1933,
as amended.

 

[SIGNATURE
OF HOLDER]

 

Name of Warrant Holder: ________________________________________________________________________

Signature of Authorized Signatory of Warrant
Holder: _________________________________________________

Name of Authorized Signatory: ___________________________________________________________________

Title of Authorized Signatory: ____________________________________________________________________

Date: ________________________________________________________________________________________

 

 

 

    	 

    	 

    

 

ASSIGNMENT FORM

 

(To assign the foregoing warrant, execute

this form and supply required information.

Do not use this form to exercise the warrant.)

 

 

 

FOR VALUE RECEIVED,
[____] all of or [_______] shares of the foregoing Warrant and all rights evidenced thereby are hereby assigned to

 

_______________________________________________
whose address is

 

_______________________________________________________________.

 

 

 

_______________________________________________________________

 

Dated: ______________,
_______

 

 

Holder’s Signature:_____________________________

 

Holder’s Address:_____________________________

 

_____________________________

 

 

 

Signature Guaranteed: ___________________________________________

 

 

NOTE: The signature to this Assignment Form
must correspond with the name as it appears on the face of the Warrant, without alteration or enlargement or any change whatsoever,
and must be guaranteed by a bank or trust company. Officers of corporations and those acting in a fiduciary or other representative
capacity should file proper evidence of authority to assign the foregoing Warrant.Exhibit 10.3

DigiPath Corp

 

CONSULTING, CONFIDENTIALITY AND PROPRIETARY
RIGHTS AGREEMENT

 

This Consulting, Confidentiality
and Proprietary Rights Agreement ("Agreement") is entered into as of the 19th day of April 2014 (the “Effective
Date”) by and between DigiPath Corp., a Kansas corporation (the “Company”), Eric Stoppenhagen, an individual
(“Consultant”).

 

WHEREAS, the Company desires
to engage Consultant to provide certain services as set forth on Schedule A attached hereto and as specified from time to time
by the Company.

 

NOW, THEREFORE, in consideration
of the foregoing and the mutual covenants and conditions contained herein, the parties hereto agree as follows:

 

1. Engagement. The
Company hereby engages Consultant to perform those duties set forth in the Schedule A attached hereto and such other duties as
may be requested from time to time by the Company. Consultant hereby accepts such engagement upon the terms and subject to conditions
set forth in this Agreement.

 

2. Compensation.
For the services rendered by Consultant under this Agreement, the Company shall pay to Consultant the compensation specified in
the Schedule A, subject to the terms and conditions set forth in this Agreement.

 

3. Term and Survivability.
The term of this Agreement shall be for a period of one year from the Effective Date and may be terminated during that time with
30 days’ notice by either party. In addition, this Agreement may be terminated if Company materially fails to perform or
comply with this Agreement or any material provision hereof. Termination shall be effective five (5) days after notice of such
material failure to perform or comply with this Agreement or any material provision hereof to the defaulting party if the defaults
have not been cured within such five (5) day period. Upon termination of this Agreement the following sections of this Agreement
shall survive such termination: Sections 3, 5, 6, 7, 8, 10, 12, 13, and Schedule A Sections 4.2, 4.3 and 4.4. The rights in Schedule
A Sections 4.2, 4.3 and 4.4 shall survive indefinitely unless otherwise agreed to by the Consultants.

 

4. Costs and Expenses
of Consultant’s Performance. Except as set forth on the Schedule A, all costs and expenses of Consultant’s performance
hereunder shall be borne by the Consultant.

 

5. Taxes. As an
independent contractor, Consultant acknowledges and agrees that it is solely responsible for the payment of any taxes and/or assessments
imposed on account of the payment of compensation to, or the performance of services by Consultant pursuant this Agreement, including,
without limitation, any unemployment insurance tax, federal and state income taxes, federal Social Security (FICA) payments, and
state disability insurance taxes. The Company shall not make any withholdings or payments of said taxes or assessments with respect
to amounts paid to Consultant hereunder; provided, however, that if required by law or any governmental agency, the Company shall
withhold such taxes or assessments from amounts due Consultant, and any such withholding shall be for Consultant's account and
shall not be reimbursed by the Company to Consultant. Consultant expressly agrees to make all payments of such taxes, as and when
the same may become due and payable with respect to the compensation earned under this Agreement.

 

6. Confidentiality.
Consultant agrees that Consultant will not, except when required by applicable law or order of a court, during the term of this
Agreement or thereafter, disclose directly or indirectly to any person or entity, or copy, reproduce or use, any Trade Secrets
(as defined below) or Confidential Information (as defined below) or other information treated as confidential by the Company known,
learned or acquired by the Consultant during the period of the Consultant's engagement by the Company. For purposes of this Agreement,
"Confidential Information" shall mean any and all Trade Secrets, knowledge, data or know-how of the Company, any of its
affiliates or of third parties in the possession of the Company or any of its affiliates, and any nonpublic technical, training,
financial and/or business information treated as confidential by the Company or any of its affiliates, whether or not such information,
knowledge, Trade Secret or data was conceived, originated, discovered or developed by Consultant hereunder. For purposes of this
Agreement, "Trade Secrets" shall include, without limitation, any formula, concept, pattern, processes, designs, device,
software, systems, list of customers, training manuals, marketing or sales or service plans, business plans, marketing plans, financial
information, or compilation of information which is used in the Company's business or in the business of any of its affiliates.
Any information of the Company or any of its affiliates which is not readily available to the public shall be considered to be
a Trade Secret unless the Company advises Consultant in writing otherwise. Consultant acknowledges that all of the Confidential
Information is proprietary to the Company and is a special, valuable and unique asset of the business of the Company, and that
Consultant's past, present and future engagement by the Company has created, creates and will continue to create a relationship
of confidence and trust between the Consultant and the Company with respect to the Confidential Information. Furthermore, Consultant
shall immediately notify the Company of any information which comes to its attention which might indicate that there has been a
loss of confidentiality with respect to the Confidential Information. In such event, Consultant shall take all reasonable steps
within its power to limit the scope of such loss.

 

7. Return of the Company’s
Proprietary Materials. Consultant agrees to deliver promptly to the Company on termination of this Agreement for whatever reason,
or at any time the Company may so request, all documents, records, artwork, designs, data, drawings, flowcharts, listings, models,
sketches, apparatus, notebooks, disks, notes, copies and similar repositories of Confidential Information and any other documents
of a confidential nature belonging to the Company, including all copies, summaries, records, descriptions, modifications, drawings
or adaptations of such materials which Consultant may then possess or have under its control. Concurrently with the return of such
proprietary materials to the Company, Consultant agrees to deliver to the Company such further agreements and assurances to ensure
the confidentiality of proprietary materials. Consultant further agrees that upon termination of this Agreement, Consultant's,
employees, consultants, agents or independent contractors shall not retain any document, data or other material of any description
containing any Confidential Information or proprietary materials of the Company.

 

8. Assignment of Proprietary
Rights. Other than the Proprietary Rights listed on the Schedule B attached hereto, if any, Consultant hereby assigns and transfers
to the Company all right, title and interest that Consultant may have, if any, in and to all Proprietary Rights (whether or not
patentable or copyrightable) made, conceived, developed, written or first reduced to practice by Consultant, whether solely or
jointly with others, during the period of Consultant's engagement by the Company which relate in any manner to the actual or anticipated
business or research and development of the Company, or result from or are suggested by any task assigned to Consultant or by any
of the work Consultant has performed or may perform for the Company.

 

Consultant acknowledges
and agrees that the Company shall have all right, title and interest in, among other items, all research information and all documentation
or manuals related thereto that Consultant develops or prepares for the Company during the period of Consultant's engagement by
the Company and that such work by Consultant shall be work made for hire and that the Company shall be the sole author thereof
for all purposes under applicable copyright and other intellectual property laws. Other than the Proprietary Rights listed on the
Schedule B attached hereto, Consultant represents and covenants to the Company that there are no Proprietary Rights relating to
the Company's business which were made by Consultant prior to Consultant's engagement by the Company. Consultant agrees promptly
to disclose in writing to the Company all Proprietary Rights in order to permit the Company to claim rights to which it may be
entitled under this Agreement. With respect to all Proprietary Rights which are assigned to the Company pursuant to this Section
8, Consultant will assist the Company in any reasonable manner to obtain for the Company's benefit patents and copyrights thereon
in any and all jurisdictions as may be designated by the Company, and Consultant will execute, when requested, patent and copyright
applications and assignments thereof to the Company, or other persons designated by the Company, and any other lawful documents
deemed necessary by the Company to carry out the purposes of this Agreement. Consultant will further assist the Company in every
way to enforce any patents, copyrights and other Proprietary Rights of the Company.

 

9. Trade Secrets of
Others. Consultant represents to the Company that its performance of all the terms of this Agreement does not and will not
breach any agreement to keep in confidence proprietary information or trade secrets acquired by Consultant in confidence or in
trust prior to its engagement by the Company, and Consultant will not disclose to the Company, or induce the Company to use, any
confidential or proprietary information or material belonging to others. Consultant agrees not to enter into any agreement, either
written or oral, in conflict with this Agreement.

 

10. Other Obligations.
Consultant acknowledges that the Company, from time to time, may have agreements with other persons which impose obligations or
restrictions on the Company regarding proprietary rights made or developed during the course of work hereunder or regarding the
confidential nature of such work. Consultant agrees to be bound by all such obligations and restrictions and to take all action
necessary to discharge the obligations of the Company hereunder.

 

11. Independent Contractor.
Consultant shall not be deemed to be an employee or agent of the Company for any purpose whatsoever. Consultant shall have the
sole and exclusive control over its employees, consultants or independent contractors who provide services to the Company, and
over the labor and employee relations policies and policies relating to wages, hours, working conditions or other conditions of
its employees, consultants or independent contractors.

 

12. Non-Solicit.
Consultant will not, during the term this Agreement and for one year thereafter, directly or indirectly (whether as an owner, partner,
shareholder, agent, officer, director, employee, independent contractor, consultant, or otherwise) with or through any individual
or entity: (i) employ, engage or solicit for employment any individual who is, or was at any time during the twelve-month period
immediately prior to the termination of this Agreement for any reason, an employee of the Company, or otherwise seek to adversely
influence or alter such individual's relationship with the Company; or (ii) solicit or encourage any individual or entity that
is, or was during the twelve-month period immediately prior to the termination of this Agreement for any reason, a customer or
vendor of the Company to terminate or otherwise alter his, her or its relationship with the Company or any of its affiliates.

 

13. Equitable Remedies.
In the event of a breach or threatened breach of the terms of this Agreement by Consultant, the parties hereto acknowledge and
agree that it would be difficult to measure the damage to the Company from such breach, that injury to the Company from such breach
would be impossible to calculate and that monetary damages would therefore be an inadequate remedy for any breach. Accordingly,
the Company, in addition to any and all other rights which may be available, shall have the right of specific performance, injunctive
relief and other appropriate equitable remedies to restrain any such breach or threatened breach without showing or proving any
actual damage to the Company.

 

14. Governing Law.
This Agreement shall be governed, construed and interpreted in accordance with the internal laws of the State of Kansas. In the
event a judicial proceeding is necessary, the sole forum for resolving disputes arising under or relating to this Agreement are
the Municipal and Superior Courts for Sedgwick County, Kansas or the Federal District Court in Sedgwick County, Kansas and all
related appellate courts, and the parties hereby consent to the jurisdiction of such courts, and that venue shall be in Sedgwick
County, Kansas.

 

15. Entire Agreement:
Modifications and Amendments. The terms of this Agreement are intended by the parties as a final expression of their agreement
with respect-to such terms as are included in this Agreement and may not be contradicted by evidence of any prior or contemporaneous
agreement. The Schedules A and B referred to in this Agreement is incorporated into this Agreement by this reference. This Agreement
may not be modified, changed or supplemented, nor may any obligations hereunder be waived or extensions of time for performance
granted, except by written instrument signed by the parties or by their agents duly authorized in writing or as otherwise expressly
permitted herein.

 

16. Attorneys Fees.
Should any party institute any action or proceeding to enforce this Agreement or any provision hereof, or for damages by reason
of any alleged breach of this Agreement or of any provision hereof, or for a declaration of rights hereunder, the prevailing party
in any such action or proceeding shall be entitled to receive from the other party all costs and expenses, including reasonable
attorneys' fees, incurred by the prevailing party in connection with such action or proceeding. To the extent the Consultant is
the prevailing party, the Company shall pay the Consultant at a rate of $300 per hour for any time spent related to such action
or proceeding. If the Company institutes any action or proceeding, prior to submitting such action or proceeding the Company shall
place in an attorney’s escrow account of the Consultants choosing $100,000.

 

17. Assignment.
This Agreement and the rights, duties and obligations hereunder may be assigned or delegated by Consultant.

 

18. Binding Effect:
Successors and Assignment. This Agreement and the provisions hereof shall be binding upon each of the parties, their successors
and permitted assigns.

 

19. Validity. This
Agreement is intended to be valid and enforceable in accordance with its terms to the fullest extent permitted by law. If any provision
of this Agreement is found to be invalid or unenforceable by any court of competent Jurisdiction, the invalidity or unenforceability
of such provision shall not affect the validity or enforceability of all the remaining provisions hereof.

 

20. Notices. All
notices and other communications hereunder shall be in writing and, unless otherwise provided herein, shall be deemed duly given
if delivered personally or by telecopy or mailed by registered or certified mail (return receipt requested) or by Federal Express
or other similar courier service to the parties at the following addresses or (at such other address for the party as shall be
specified by like notice). Additionally, an email shall be sent with a copy of all written notices.

 

(i) If to the Company:

DigiPath Corp

			

			

			

 

(ii) If to the Consultant:

 

 

 

Any such notice, demand
or other communication shall be deemed to have been given on the date personally delivered or as of the date mailed, as the case
may be.

 

 

 

IN WITNESS WHEREOF, the parties hereto have
executed this Consulting, Confidentiality, and Proprietary Rights Agreement as of the Effective Date written above.

 

CONSULTANT

 

 

By:___/s/
Eric Stoppenhagen_________________

			Name; Eric Stoppenhagen

 

 

DigiPath Corp

 

 

By:_____/s/
Steven D. Barbee_______________

			Name: Steven D. Barbee

			Title: President and Chairman

Accepted and Acknowledged
by:

 

DigiPath, Inc.

 

 

By:____/s/
Todd Denkin_______________________

Name: Todd Denkin

Title: President

 

 

    	 

    	 

    

Schedule
A

 

TITLE, DUTIES AND OPERATIONAL
RESPONSIBILITIES:

 

1. Title and Operational
Responsibilities

 

		§	Consultant will provide the services of Vice President, Business Development

		§	Company shall have the right to introduce and represent Consultant to those outside of the Company
as Vice President, Business Development

		§	Consultant shall report to the President

 

2.SCHEDULE AND COMITTMENT
OF TIME:

Consultant is
expected to devote as much time as needed to assist in selling DigiPath products, and fulfilling such scope of work as both parties
agree in writing.

 

3.REPORTING SCHEDULE:

Consultant shall
report regularly, and not less frequent than once per month, to the Company his actions on behalf of the Company. The Consultant
shall keep a detailed list of all communications as required by the Company.

 

4.COMPENSATION AND
PAYMENT TERMS:

 

4.1Consultant
shall be paid $10,000 per month in consulting fees, plus fair and reasonable business expense reimbursement. Such payments shall
be terminated upon the resignation of Consultant.

4.2Consultant
is hereby granted a five year Common Stock Purchase Warrant as set forth in Exhibit A (“Warrants”). The Warrant will
entitle the Consultant to purchase 3,000,000 shares of common stock at an exercise price of $0.10. No equity or debt shall be issued
in the Company or its subsidiaries without the expressed written consent of Consultant, which shall not be unreasonably withheld.
To the extent the issuance could be dilutive the Consultant shall be made whole. The Warrants shall vest immediately and are considered
to be earned in full. Warrants shall have a cashless provision and shall not be able to be converted into more than 4.99% of the
Company’s common stock without giving a 65 days’ notice to void such provision.

 

4.3In the event
that there is ever a Change in Control , and at such time the Company’s value exceeds $1,600,000, as measured by the fair
market value of the greater of the Company or its assets, , Mr. Stoppenhagen shall be paid $300,000. Change in Control of the Company
shall be deemed to have occurred if: (i) any “Person,” as such term is used in Section 13(d) and 14(d) of the Exchange
Act (other than the Company, any trustee or other fiduciary holding securities under an employee benefit plan of the Company, or
any corporation owned, directly or indirectly, by the stockholders of the Company in substantially the same proportions as their
ownership of stock of the Company), is or becomes the “beneficial owner’ (as defined in Rule 13d-3 under the Exchange
Act), directly or indirectly, of securities of the Company representing 20% or more of the combined voting power of the Company’s
then outstanding securities; (ii) during any 12-month period (not including any period prior to the execution of this Agreement),
individuals who at the beginning of such period constitute the Board, and any new director (other than a director designated by
a person who has entered into an agreement with the company to effect a transaction described in subclauses (i), (iii) or (iv)
of this Section 4.3) whose election by the Board or nomination for election by the Company’s stockholders was approved by
a vote of at least 66 2/3 % of the members of the Board then still in office who either were Directors at the beginning of the
period or whose election or nomination for election was previously so approved, cease for any reason to constitute at least a majority
thereof; (iii) the Company’s stockholders approve a merger or consolidation of the Company with any other corporation, other
than: (A) a merger or consolidation which would result in the voting securities of the Company outstanding immediately prior thereto
continuing to represent (either by remaining outstanding or by being converted into voting securities of the surviving entity)
more than 50% of the combined voting power of the voting securities of the Company or such surviving entity outstanding immediately
after such merger or consolidation; or (B) a merger or consolidation effected to implement a recapitalization of the Company (or
similar transaction) in which no Person acquires more than 50% of the combined voting power of the Company’s then
outstanding securities; or (iv) the stockholders of the Company approve a plan of complete liquidation of the Company or an agreement
for the sale or disposition by the Company of all or substantially all of the Company’s assets.

 

 

5EXPENSES:

Company agrees to reimburse Consultant
for reasonably necessary travel expenses, and other expenses associated with working in a home office. However, should such expenses
exceed $4,000 in any given calendar month; such expenses shall be pre-approved in advance by Company in order to qualify to reimbursement.
An email authorization by an officer of Company shall be deemed a valid approval. Such payments shall be terminated upon the resignation
of Consultant.

    	 

    	 

    

Schedule B

Propriety Rights

    	 

    	 

    

Exhibit A 

COMMON STOCK PURCHASE WARRANT

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00233-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00233-of-00352.parquet"}]]